Progression of Metabolic Syndrome Severity During the Menopausal Transition

Abstract

BackgroundAfter menopause, women exhibit a higher prevalence of the metabolic syndrome (MetS) and higher risk of cardiovascular disease. However, the timing of changes in MetS severity over the menopausal transition and whether these changes differ by racial/ethnic group remain unclear.Methods and ResultsWe assessed data from 1470 women from the Atherosclerosis Risk in Communities cohort who experienced transition in menopausal status over 10 years (visits 1–4). We used linear mixed models to evaluate changes by menopausal status (premenopause, perimenopause, and postmenopause) in a MetS severity Z‐score and in the individual MetS components. While there were gradual increases in MetS severity over time across menopause stages, black women in particular exhibited more rapid progression in MetS severity during the premenopausal and perimenopausal periods than during the postmenopausal period. In the postmenopausal period (compared with prior periods), white women exhibited unfavorable decreases in high‐density lipoprotein, while black women exhibited favorable alterations in the rate of change for waist circumference, triglycerides, high‐density lipoprotein, and glucose, contributing to the slowed progression of MetS severity. These changes were all observed after adjusting for hormone replacement treatment.ConclusionsDuring menopausal transition, women exhibited rapid increases in MetS severity during the premenopausal and perimenopausal periods, with black women having significant reductions in this increase in severity during the postmenopausal period. These data suggest that the higher prevalence of MetS in postmenopausal women may be caused more by changes during the menopausal transition than by postmenopause. These findings may thus have implications regarding the timing of cardiovascular risk relative to menopause.

Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course

“…Potential factors that may be relevant to the equalisation in incidence rates of type 2 diabetes in men and women among older adults could include the changes related to the hormonal transition that occurs during the menopause in women at 50 years of age. For example, increased visceral fat deposition among women after menopause may promote increased insulin resistance and elevated incidence of the metabolic syndrome in older women [70,71].…”

Vitamin D and Indices of Bone and Carbohydrate Metabolism in Postmenopausal Women Subjected to a 12-Week Aerobic Training Program—The Pilot Study

“…Hormonal changes and lifestyle modifications, which are characteristic for the menopause period, often lead to various impairments of metabolic processes [1,2]. Aerobic exercises are often recommended to elderly or overweight individuals as the prevention of metabolic disturbances and functional limitations [3,4].…”

Results of the use of physical therapy for metabolic syndrome according to anthropometric studies

“…The most vulnerable period of women's transitional age is premenopause, that is, the initial period of decreased ovarian function (mainly after 45 years and before menopause), which is accompanied by a critical decrease in estrogen levels. The implementation of estrogen deficiency during menopause includes an effect on the metabolism of lipoproteins, a direct effect on the biochemical processes in the vessel wall through specific estrogen receptors, as well as an indirect effect through the metabolism of glucose, insulin, homocysteine, haemostasis system (Su, et al, 2015;Gurka, et al, 2016).…”